FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Sell Opinion On Shares Of Extra Space Storage

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target price by $5 to $125, 15.5x our 2026 P/FFO estimate, below self-storage peers (16.7x) given EXR's weak NOI growth outlook and elevated debt levels. We decrease our 2026 FFO estimate by $0.20 to $8.04 and lower 2027 by $0.21 to $8.31. Despite a stronger Q1 same-store performance than expected, management did not increase guidance, which we believe is due to macroeconomic factors that are affecting new customer demand growth (primarily higher gas prices and inflation). These trends have been more pronounced in Sun Belt markets (similar to all self-storage REITs), as the excess supply has severely limited rental growth in the past 18 months. We believe 2H 2026 will have weaker same-property performance, even if the macroeconomic environment improves due to stronger Y/Y comps from 2H 2025. We also see a new risk that PSA's partnership with Welltower Inc (WELL) may negatively impact EXR's value proposition for its third-party management platform.

Related Articles

Australia

ManpowerGroup Sells Jefferson Wells US Business to Sikich

ManpowerGroup (MAN) said Thursday it is selling its Jefferson Wells US business to Sikich in a transaction valued at $100 million.ManpowerGroup will recognize a gain on sale in Q2, the company said, adding that the transaction closed on Thursday.The company will receive net cash proceeds at closing of approximately $88 million after working capital and other items, and it plans to use the proceeds to strengthen its balance sheet, according to a statement.Price: $30.40, Change: $-0.28, Percent Change: -0.91%

$MAN
Sectors

Sector Update: Financial Stocks Advance Thursday Afternoon

Financial stocks were higher Thursday afternoon, with the NYSE Financial Index rising 0.8% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.3%.The Philadelphia Housing Index was up 1.1%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1%.Bitcoin (BTC-USD) rose 0.6% to $76,227, and the yield for 10-year US Treasuries was decreasing 2.4 basis points to 4.39%.In economic news, the core personal consumption expenditures price index, the Federal Reserve's preferred inflation gauge, rose to 3.2% year-on-year in March from 3%, meeting expectations. It climbed 0.3% month-over-month, down from the 0.4% reported in February.US economic growth, measured by gross domestic product, rose by 2.0% in Q1 after a 0.5% gain in Q4, slower than a 2.3% increase expected in a survey compiled by Bloomberg.US initial jobless claims fell to 189,000 in the week ended April 25 from an upwardly revised 215,000 in the previous week, against expectations for a rise to 212,000 in a Bloomberg survey.In sector news, the US Senate unanimously passed Thursday a rule prohibiting its members from trading on prediction markets, effective immediately, CNBC reported.In corporate news, KKR (KKR) is considering selling the Flora Food Group spreads business, seeking to strike a deal at a valuation of up to $10 billion, the Financial Times reported. KKR shares climbed 4.2%.Mastercard's (MA) Q1 results outpaced Wall Street's estimates, but the company said that the Middle East conflict was impacting spending on cross-border travel. Its shares fell 4.7%.Brookfield Asset Management (BAM) is preparing to file draft documents as early as May for an initial public offering of Indian telecommunications tower operator Altius Telecom Infrastructure Trust, Bloomberg reported. Brookfield shares rose 3.9%.

$BAM$KKR$MA
Research

Research Alert: CFRA Maintains Buy Rating On Shares Of The Cigna Group

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target to $330 from $320, based on a 10.9x multiple of our 2026 EPS estimate, near CI's five-year historical forward average of 11.2x. We think CI's multiple balances pharmaceutical business momentum in CI's Evernorth segment and a timely portfolio shift toward more commercial exposure, offset by near-term challenges around higher medical costs across the managed care space. We raise our 2026 EPS estimate by $0.01 to $30.35 and lower 2027's by $0.09 to $33.42. Following Q1 results that beat consensus views, CI's annual Medical Care Ratio (MCR) guidance was maintained at 83.7% to 84.7% for 2026, suggesting cost discipline within a challenging operating environment for managed care. The company plans to exit the Individual ACA Exchange market by year-end 2026, citing the relatively small exposure relative to other parts of CI's portfolio and challenges with meaningfully scaling operations.

$CI